VOYA Investment Management’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
11,823
+753
| +7% | +$7.22K | ﹤0.01% | 2458 |
|
|
2025
Q1 | $69.4K | Sell |
11,070
-619
| -5% | -$3.88K | ﹤0.01% | 2500 |
|
|
2024
Q4 | $94.9K | Buy |
11,689
+325
| +3% | +$2.64K | ﹤0.01% | 2590 |
|
|
2024
Q3 | $205K | Sell |
11,364
-327
| -3% | -$5.91K | ﹤0.01% | 2466 |
|
|
2024
Q2 | $120K | Buy |
11,691
+672
| +6% | +$6.92K | ﹤0.01% | 2622 |
|
|
2024
Q1 | $117K | Sell |
11,019
-1,824
| -14% | -$19.4K | ﹤0.01% | 2597 |
|
|
2023
Q4 | $117K | Hold |
12,843
| – | – | ﹤0.01% | 2719 |
|
|
2023
Q3 | $133K | Buy |
12,843
+2,798
| +28% | +$29K | ﹤0.01% | 2661 |
|
|
2023
Q2 | $144K | Buy |
+10,045
| New | +$144K | ﹤0.01% | 2690 |
|
|
2021
Q4 | – | Sell |
-7,968
| Closed | -$256K | – | 2814 |
|
|
2021
Q3 | $256K | Hold |
7,968
| – | – | ﹤0.01% | 2431 |
|
|
2021
Q2 | $270K | Buy |
+7,968
| New | +$270K | ﹤0.01% | 2425 |
|